These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada. Leal JR, Conly J, Weaver R, Wick J, Henderson EA, Manns B, Ronksley P. Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884 [Abstract] [Full Text] [Related]
4. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective. Leblanc S, Blein C, Andremont A, Bandinelli PA, Galvain T. Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805 [Abstract] [Full Text] [Related]
5. Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Tabak YP, Zilberberg MD, Johannes RS, Sun X, McDonald LC. Infect Control Hosp Epidemiol; 2013 Jun; 34(6):588-96. PubMed ID: 23651889 [Abstract] [Full Text] [Related]
6. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016. Mollard S, Lurienne L, Heimann SM, Bandinelli PA. J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052 [Abstract] [Full Text] [Related]
8. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pakyz A, Carroll NV, Harpe SE, Oinonen M, Polk RE. Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438 [Abstract] [Full Text] [Related]
9. The economic burden of Clostridium difficile. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576 [Abstract] [Full Text] [Related]
11. The burden of Clostridium difficile in surgical patients in the United States. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114 [Abstract] [Full Text] [Related]
12. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. J Hosp Infect; 2012 May; 81(1):1-14. PubMed ID: 22498638 [Abstract] [Full Text] [Related]
14. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals. Le Monnier A, Duburcq A, Zahar JR, Corvec S, Guillard T, Cattoir V, Woerther PL, Fihman V, Lalande V, Jacquier H, Mizrahi A, Farfour E, Morand P, Marcadé G, Coulomb S, Torreton E, Fagnani F, Barbut F, GMC Study Group. J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518 [Abstract] [Full Text] [Related]
15. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery. Egorova NN, Siracuse JJ, McKinsey JF, Nowygrod R. Ann Vasc Surg; 2015 Oct; 29(4):792-800. PubMed ID: 25595110 [Abstract] [Full Text] [Related]
16. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre. van Beurden YH, Bomers MK, van der Werff SD, Pompe EAPM, Spiering S, Vandenbroucke-Grauls CMJE, Mulder CJJ. J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013 [Abstract] [Full Text] [Related]